You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The decision comes amid a general slowdown in the market, yet also showcases the continued appeal of ancestry-related applications.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
Gene by Gene and its FamilyTreeDNA division offer a range of genetic testing services, including for ancestry, forensics, paternity, and COVID-19.
In early 2020, the direct-to-consumer genetic test developer laid off about 14 percent of its workforce amid a restructuring of its consumer business.
The PCR test is the first offering from the firm, formerly known as Concepta, since it acquired Manchester-based startup The Genome Store in November.
The genetic testing company said its orders for traditional tests have also rebounded and are on track for growth in the second half of 2020.
The next iteration of Ancestry's Health experience seeks to provide customers with actionable information about certain commonly inherited health conditions.
Consumer Reports points out a regulatory gap in the US surrounding direct-to-consumer genetic tests that it says lawmakers should address.
Stat News offers ways consumer genetic testing companies could address racial disparities.
The investment bank gave shares of the Temple City, California-based genetic testing company a buy rating and a $20 price target.
Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner.
Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.
A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.
In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.
